en
Scientific article
English

Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT

Published inBritish Journal of Haematology, vol. 182, no. 3, p. 418-422
Publication date2018
Abstract

Allogeneic Haematopoietic Stem Cell Transplant (allo-HSCT) remains the only curative approach for Myelofibrosis (MF). Scarce information exists in the literature on the outcome and, indeed, management of those MF patients who relapse following transplant. We hereby report on the management and outcome of 202 patients who relapsed post allo-HSCT for MF.

Citation (ISO format)
MCLORNAN, Donal P et al. Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT. In: British Journal of Haematology, 2018, vol. 182, n° 3, p. 418–422. doi: 10.1111/bjh.15407
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0007-1048
322views
0downloads

Technical informations

Creation11/23/2018 2:51:00 PM
First validation11/23/2018 2:51:00 PM
Update time03/15/2023 4:07:58 PM
Status update03/15/2023 4:07:56 PM
Last indexation01/17/2024 5:18:52 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack